We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCARW
1676
CALL
DELISTED
Healthcare Services Acquisition Corporation Warrant
HCARW
$3.42M 0.01%
349,450
+149,450
+75% +$64.1K
QDROW
1677
CALL
DELISTED
Quadro Acquisition One Corp. Warrant
QDROW
$3.42M 0.01%
349,421
ENB icon
1678
Enbridge
ENB
$121B
$3.41M 0.01%
74,000
-717,223
-91% -$30.7M
FLYA.WS
1679
CALL
DELISTED
SOAR Technology Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FLYA.WS
$3.4M 0.01%
335,686
XENT
1680
DELISTED
Intersect ENT, Inc
XENT
$3.39M 0.01%
121,032
+55,474
+85% +$1.52M
JD icon
1681
JD.com
JD
$42.9B
$3.38M 0.01%
58,501
-806,761
-93% -$54.8M
ORGO icon
1682
Organogenesis Holdings
ORGO
$326M
$3.38M 0.01%
+443,778
New +$3.43M
MX icon
1683
Magnachip Semiconductor
MX
$118M
$3.38M 0.01%
199,969
+171,636
+606% +$3.08M
BVH
1684
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$3.38M 0.01%
114,280
-67,029
-37% -$2.03M
RACB
1685
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$3.38M 0.01%
345,934
+17,234
+5% +$168K
AMG icon
1686
Affiliated Managers Group
AMG
$9.78B
$3.38M 0.01%
23,944
+22,092
+1,193% +$3.17M
KIIIW
1687
CALL
DELISTED
Kismet Acquisition Three Corp. Warrant
KIIIW
$3.38M 0.01%
344,570
RDUS
1688
DELISTED
Radius Health, Inc.
RDUS
$3.38M 0.01%
382,507
+187,055
+96% +$1.42M
DE icon
1689
Deere & Co
DE
$173B
$3.37M 0.01%
8,119
-60,390
-88% -$23.1M
CVAC
1690
DELISTED
CureVac
CVAC
$3.37M 0.01%
+171,782
New +$3.43M
DYN icon
1691
Dyne Therapeutics
DYN
$4.28B
$3.37M 0.01%
349,279
TRUG icon
1692
TruGolf
TRUG
$1.3M
$3.37M 0.01%
679
+1
+0.1% +$4.94K
ALTIW
1693
CALL
DELISTED
AlTi Global Inc Warrant
ALTIW
$3.35M 0.01%
340,010
PDOT.WS
1694
CALL
DELISTED
Peridot Acquisition Corp. II Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PDOT.WS
$3.35M 0.01%
342,956
APCA
1695
DELISTED
AP Acquisition Corp
APCA
$3.35M 0.01%
+334,752
New +$3.33M
APGB.WS
1696
CALL
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$3.34M 0.01%
340,739
KODK icon
1697
Kodak
KODK
$812M
$3.33M 0.01%
+508,656
New +$2.42M
PPGHW
1698
CALL
DELISTED
Poema Global Holdings Corp. Warrant
PPGHW
$3.32M 0.01%
336,736
-18,264
-5% -$22.4K
APTV icon
1699
Aptiv
APTV
$12.6B
$3.32M 0.01%
+27,747
New +$3.69M
FTVI
1700
DELISTED
FinTech Acquisition Corp. VI Class A Common Stock
FTVI
$3.32M 0.01%
337,913

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.